MPUMALANGA – 29 May 2026 – President Cyril Ramaphosa is set to officially launch the national rollout of Lenacapavir, a new long-acting injectable HIV prevention treatment, on 5 June 2026 in Secunda, Mpumalanga. The launch marks a significant step forward in South Africa’s ongoing efforts to reduce new HIV infections and strengthen the country’s response to HIV/AIDS. Lenacapavir, a twice-yearly injectable prevention option, offers a new approach to HIV prevention by providing
